Search results
Results from the WOW.Com Content Network
In the first quarter of its fiscal year 2025, ending on Aug. 31, revenue of $200 million increased by 13% year over year. ... If this prediction comes true, Tilray's stock will almost certainly ...
Industry analysts forecast the market could reach $444 billion by 2030, representing a compound annual growth rate (CAGR) of 34.03% from 2023. ... Tilray has seen its stock price plummet a ...
Heading into the news, Wall Street analysts anticipated Tilray would report sales of $216.3 million for its fiscal second quarter of 2025, ended Nov. 30, but Tilray actually collected just $211 ...
In its first quarter of 2025, the results of which were published in October, Tilray's net revenue rose 13% year over year to hit $200 million for the first time, aided greatly by a 132% rise in ...
For the period ending Aug. 31, its sales grew by 13% year over year to $200 million. But of that total, less than one-third (31%) of sales actually came from its cannabis operations.
Tilray Brands (NASDAQ: TLRY) is no exception as it looks to be on track for another tough year, with its stock price down more than 40% thus far in 2024, entering trading on Monday.
Tilray Brands (NASDAQ: TLRY) shares still aren't delivering on what investors may have hoped for, falling by 25% during the past 12 months. Tilray isn't the same company it was a couple of years ...
Considering the regulatory and operational hurdles involved in such expansion, the average Wall Street price target for Tilray's stock suggests a modest 18% growth potential over the forthcoming year.